Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Depreciation & Amortization - Total (2016 - 2019)

Historic Depreciation & Amortization - Total for Xtant Medical Holdings (XTNT) over the last 10 years, with Q3 2019 value amounting to $800000.0.

  • Xtant Medical Holdings' Depreciation & Amortization - Total changed 0.0% to $800000.0 in Q3 2019 from the same period last year, while for Jun 2020 it was $800000.0, marking a year-over-year decrease of 7419.35%. This contributed to the annual value of $3.2 million for FY2018, which is 1578.95% down from last year.
  • As of Q3 2019, Xtant Medical Holdings' Depreciation & Amortization - Total stood at $800000.0, which was down 0.0% from $700000.0 recorded in Q2 2019.
  • Xtant Medical Holdings' Depreciation & Amortization - Total's 5-year high stood at $2.0 million during Q3 2017, with a 5-year trough of -$100000.0 in Q4 2017.
  • Its 5-year average for Depreciation & Amortization - Total is $653061.0, with a median of $747850.0 in 2016.
  • Per our database at Business Quant, Xtant Medical Holdings' Depreciation & Amortization - Total tumbled by 13998.75% in 2017 and then soared by 90000.0% in 2018.
  • Xtant Medical Holdings' Depreciation & Amortization - Total (Quarter) stood at $112750.0 in 2015, then skyrocketed by 121.8% to $250078.0 in 2016, then plummeted by 139.99% to -$100000.0 in 2017, then skyrocketed by 900.0% to $800000.0 in 2018, then changed by 0.0% to $800000.0 in 2019.
  • Its Depreciation & Amortization - Total was $800000.0 in Q3 2019, compared to $700000.0 in Q2 2019 and $800000.0 in Q1 2019.